Teva Pharm expects to start paying U.S. opioid settlement in 2023 By Reuters
Teva Gains 6.4% on Another Opioid Case Settlement
Teva Pharmaceutical Industries Limited (NYSE:TEVA) is largely controlled by institutional shareholders who own 55% of the company - Simply Wall St News
Ex-pharmaceutical company boss faces insider trading charges over Teva deal | The Times of Israel
Teva Pharmaceutical Industries (NYSE: TEVA) Rings the NYSE Closing Bell - YouTube